CT SB00352

Allows prescribing practitioners to issue standing orders (nonpatient-specific prescriptions) for opioid antagonists via intranasal or auto-injection delivery systems to people at risk of overdose or those in position to assist them, with pharmacists protected from liability when dispensing under such orders.

Permits licensed pharmacists certified by the Commissioner of Consumer Protection to prescribe opioid antagonists and dispense them under standing orders, provided they deliver appropriate training and maintain dispensing records.

Limits initial opioid drug prescriptions for adults to a seven-day supply and all opioid prescriptions for minors to a seven-day supply, with required discussion of risks for minors.

Allows prescribing practitioners to exceed the seven-day supply limit if medically necessary for acute conditions, chronic pain, cancer-related pain, or palliative care, with documentation required in the patient's medical record.

Exempts medications for opioid abuse or dependence treatment, including opioid agonists and antagonists, from the seven-day supply limitations.